[1]
B. Babiarczyk, A. Haratyk, and B. Guzak, “Quality of life of patients with diabeticretinopathy receiving anti-VEGF therapy”, Piel21w, vol. 24, no. 3(92), pp. 241–249, Sep. 2025, doi: 10.12923/pielxxiw-2025-0025.